22
total announcements
AGARWALEYE.NS · 15 min delayed
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has informed the Exchange about Copy of Newspaper Publication regarding the Sixteenth Annual General Meeting of the Company, Instructions for e-Voting and Other Related Information.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has convened its 16th Annual General Meeting (AGM) for the financial year 2025-2026, to be held on September 21, 2026, through video conferencing. The meeting will consider the annual report and other business items. The company has also made its annual report available on its website.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has launched the World's First Pinhole Pupilloplasty (PPP) Centre at its subsidiary Dr. Agarwal's Eye Hospital Limited in Chennai, India.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has informed the Exchange about the schedule of analyst/investor meet and conferences to be held on September 16 and 17-18, 2026, in Gurgaon and Mumbai respectively.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has informed the Exchange about the transcript of the discussion on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026, at the Analyst / Earnings conference call held on August 04, 2026. The transcript is available on the Company's website.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has made available the audio recording of its analyst/earnings conference call for the quarter ended June 30, 2026, on its website.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per Regulation 32(6) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, and Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report, issued by ICRA Limited, Monitoring Agency, confirms that the utilization of the proceeds of the Initial Public Offer (IPO) is in line with the objects of the issue.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has informed the Exchange about Investor Presentation for Q1 FY27. The presentation includes unaudited financial results for the quarter ended June 30, 2026. The company has also scheduled an analyst/earnings conference call to discuss the results.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations growing by 26.0% YoY to ₹614 Crores, total income growing by 23.9% YoY to ₹620 Crores, IND-AS EBITDA growing by 25.2% YoY to ₹177 Crores, and PAT growing by 44.6% YoY to ₹55 Crores.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has scheduled a board meeting on August 4, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, and will host an earnings/analyst conference call to discuss the results.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has published a newspaper advertisement for the Notice of hearing of the Company's Petition in relation to the Scheme of amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has submitted a disclosure under SEBI Takeover Regulations, indicating a potential takeover or acquisition activity.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has allotted 43,155 equity shares to eligible employees under the Employees Stock Option Scheme 2022, increasing the company's paid-up equity share capital to ₹ 31,70,26,183.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has issued a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the details of securities dematerialized/rematerialized during the quarter ended June 30, 2026.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has announced the voting results and Consolidated Scrutinizer's Report on the NCLT convened meeting of the Unsecured Creditors, approving the Scheme of amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited held a meeting of unsecured creditors on July 2, 2026, to consider and approve the Scheme of Amalgamation of Dr. Agarwal's Eye Hospital Limited with Dr. Agarwal's Health Care Limited. The meeting was adjourned due to lack of quorum, but the resolutions were proposed and voting was conducted through e-voting and polling papers.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has announced the voting results and Consolidated Scrutinizer's Report on the NCLT convened meeting of the Secured Creditors held on July 02, 2026, approving the Scheme of amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited held a meeting of secured creditors on July 2, 2026, to consider and approve the scheme of amalgamation of Dr. Agarwal's Eye Hospital Limited with Dr. Agarwal's Health Care Limited. The meeting was convened by the National Company Law Tribunal (NCLT) and was attended by 2 secured creditors. The resolution was passed with a special majority as prescribed under Section 230(6) of the Companies Act, 2013.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited has submitted the Exchange a copy of the Scrutinizer's report of the Court Convened General Meeting held on July 02, 2026, and informed the Exchange regarding voting results of the Scheme of amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited.
Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited held a shareholders meeting on July 02, 2026, to consider and approve the Scheme of Amalgamation of Dr. Agarwal's Eye Hospital Limited with Dr. Agarwal's Health Care Limited. The meeting was convened by the National Company Law Tribunal (NCLT) and was attended by 47 shareholders, including 17 promoters and 30 public shareholders. The resolution to approve the Scheme was passed with the required quorum.